LivaNova (LIVN) Non Operating Investment Income (2017 - 2018)

LivaNova (LIVN) posted Non Operating Investment Income of $11.5 million for Q1 2018, down 70.87% sequentially from $39.4 million in Q2 2017.

LivaNova (LIVN) Non Operating Investment Income (2017 - 2018) Analysis & Trends

LivaNova has reported Non Operating Investment Income for 2 years, with the latest figure at $11.5 million in Q1 2018.

Quarterly Non Operating Investment Income changed N/A year-over-year to $11.5 million in Q1 2018, while the trailing twelve-month figure through Dec 2018 was $11.5 million (down 70.87% YoY) and the FY2018 annual result came in at $11.5 million, down 70.87% from the prior year.
Non Operating Investment Income slipped to $11.5 million in Q1 2018 per LIVN's latest filing, from $39.4 million in the prior quarter.
Over five years, Non Operating Investment Income peaked at $39.4 million in Q2 2017 and troughed at $11.5 million in Q1 2018.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non Operating Investment Income (Qtr)
1	Abbott Laboratories	199.77 Bn	194.17 Bn	7.27 Bn	-
2	Stryker	129.56 Bn	126.08 Bn	4.50 Bn	-
3	Medtronic	120.09 Bn	110.87 Bn	6.41 Bn	-
4	Boston Scientific	73.80 Bn	73.26 Bn	3.85 Bn	-
5	Edwards Lifesciences	52.68 Bn	48.43 Bn	1.35 Bn	-
6	Dexcom	34.60 Bn	32.65 Bn	830.00 Mn	-
7	GE HealthCare Technologies	34.10 Bn	31.99 Bn	2.18 Bn	-
8	Koninklijke Philips	26.45 Bn	23.12 Bn	4.55 Bn	-
9	Steris	23.20 Bn	22.72 Bn	684.20 Mn	-
10	LivaNova	4.35 Bn	3.83 Bn	273.67 Mn	-

Download Data